Document is current
Any future updates will be listed below
-
Authors
Batista, Ellencristina Silva
da Silva Rios, Thaiane
Muñoz, Vitor Rosetto
Jesus, Joyce Santos
Vasconcelos, Marcel Monteiro
da Cunha, Diogo Thimóteo
Marques-Rocha, Jose Luis
Nakandakari, Susana Castelo Branco Ramos
Lara, Roberta
da Silva, Adelino Sanchez Ramos
Pauli, José Rodrigo
Ropelle, Eduardo Rochete
Mekary, Rania Angelina
de Moura, Leandro Pereira
Camargo, Enilton Aparecido
Cintra, Dennys Esper https://orcid.org/0000-0002-7954-5630
-
Funding
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2012/07129-6)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES-001)
- License Information
-
More Information
Article History
Received: 30 March 2021
Accepted: 8 October 2021
First Online: 18 December 2021
Ethics approval and consent to participate
: This study will be conducted with the highest respect for volunteers. We followed the Declaration of Helsinki and the Ethical Guidelines for Clinical Research. This study was approved by the Ethics Committee of the Federal University of Sergipe (#80476517.2.0000.5546). Written informed consent (including for publication) was obtained before randomization in the usual manner.
: None. The Naturalis company, an Omega-3 capsule factory, was chosen among many others, after the quality of their capsules be certified by our laboratory. The company did not ask for the results, does not know anyone from the study, and did not participate in any other aspect of this study. Nor Naturalis company neither the FAPESP funder will audit the study at any time. Thus, the authors declare that they have no competing interests.
